Heart & Lung: The Journal of Acute and Critical Care
Volume 37, Issue 6 , Pages 455-465, November 2008

Predictors of smoking relapse in women with cardiovascular disease in a 30-month study: Extended analysis

  • Wen-Wen Li, RN, MS, PhD

      Affiliations

    • School of Nursing, San Francisco State University, San Francisco, California
    • Department of Community Health Systems, School of Nursing, University of California, San Francisco, California
    • Corresponding Author InformationCorresponding author: Wen-Wen Li, RN, MS, PhD, School of Nursing, San Francisco State University, 1600 Holloway Avenue, Burk Hall 383, San Francisco, CA 94132
  • ,
  • Erika S. Froelicher, RN, MPH, PhD

      Affiliations

    • Department of Physiological Nursing, School of Nursing, University of California San Francisco, San Francisco, California
    • Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, California

published online 06 October 2008.

Purpose

To identify predictors of long-term cessation after intervention for woman hospitalized with cardiovascular diseases (CVD).

Methods

A randomized clinical trial (RCT) with a 30-month follow-up was conducted, recruiting 277 woman smokers with CVD from 10 hospitals. The intervention consisted of inpatient and outpatient counseling on smoking cessation and pharmacological protocol. Psychophysiological factors and time since quitting associated with relapse in the literature were assessed in our prediction model.

Results

The nine independent variables for smoking relapse included time since quitting, group assignment, the interaction between time and group assignment, serious quit attempts and five and psychophysiological factors. Lower self-efficacy at baseline was a significant predictor of relapse (OR = 0.98, 95%CI = 0.97,0.99). Another predictor was the interaction between time and group assignment and the finding showed that for the usual care group, increase in time since quitting provided a significant protective factor (OR = 0.69, 95%CI = 0.60,0.79).

Conclusions

Cessation programs should include content on self-efficacy to help prevent relapse. The interaction between time and group warrants further investigation for its prediction for relapse.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was funded by grant No. R01H150749 (08-01-96 to 06-30-02) from the National Institutes of Health National Heart, Lung, and Blood Institute.

PII: S0147-9563(08)00137-4

doi:10.1016/j.hrtlng.2008.07.005

Heart & Lung: The Journal of Acute and Critical Care
Volume 37, Issue 6 , Pages 455-465, November 2008